ScholarWorks@Dongguk University: Kim, Hyung suk

Detailed Information

Kim, Hyung suk (김형석)

Graduate School (Department of Medicine)

Research Area

Tel 031-961-7455
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Urinary bladder neoplasms:4||Recurrence:3||Carcinoma:3||transitional cell:3||survival:3||prognosis:2||carcinoma:2||chemotherapy:2||urothelial carcinoma:2||recurrence:2||Urinary incontinence:2||disease progression:2||Prognosis:2||Health services for the aged:2||bladder cancer:2||Lower urinary tract symptoms:1||Mycobacterium bovis:1||Nbutyl n(4:1||Nnitrosodimethylamine:1||Nephrectomy:1||Nomograms:1||Oncogene:1||Oncolytic virotherapy:1||PD1 inhibitor:1||PDL1 inhibitor:1||Patient care management:1||Physicians' practice patterns:1||Propensity score:1||Radiationrecurrent prostate cancer (radiorecurrent prostate cancer):1||Renal pelvis:1||Schistosoma haematobium:1||Smoking:1||Suburethral slings:1||Surveys and questionnaires:1||Survival:1||Transitional cell:1||Transitional cell carcinoma:1||Tumor suppressor gene:1||Ureter:1||Urinary bladder neoplasm:1||Urologic diseases:1||Urological diseases:1||Urothelial carcinoma:1||Vitamin D deficiency:1||androgen deprivation therapy (ADT):1||cystectomy:1||demographic:1||egg:1||hydroxybutyl) nitrosamine:1||immune cell:1||immune checkpoint:1||immunohistochemistry:1||immunotherapy:1||laser:1||lithotripsy:1||mouse:1||muscleinvasive:1||nephrolithiasis:1||nephroureterectomy:1||network metaanalysis:1||neutrophil to lymphocyte ratio:1||overactive:1||programmed cell deathligand 1:1||prostatectomy:1||prostatic hyperplasia:1||renal cell:1||salvage local treatment:1||seasons:1||systematic review:1||systemic inflammatory response:1||ureteroscopy:1||urinary bladder:1||urinary bladder neoplasms:1||urinary catheters:1||urinary urinary tract:1||25hydroxyvitamin D:1||vitamin D:1||Antibodydrug conjugate:1||BCG vaccine:1||Bacillus CalmetteGuerin:1||Bladder:1||Bladder neoplasms:1||Blood transfusion:1||Cohort studies:1||Cystectomy:1||Disease progression:1||Erectile dysfunction:1||Gemcitabine:1||Immune checkpoint inhibitors:1||Immunotherapy:1||Ki67 antigen:1||

RSS_1.0 RSS_2.0 ATOM_1.0

30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE